A detailed history of Great Lakes Advisors, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Great Lakes Advisors, LLC holds 148,815 shares of ITCI stock, worth $10.2 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
148,815
Previous 149,552 0.49%
Holding current value
$10.2 Million
Previous $10.7 Million 3.86%
% of portfolio
0.09%
Previous 0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$64.37 - $75.65 $47,440 - $55,754
-737 Reduced 0.49%
148,815 $10.3 Million
Q4 2023

Feb 08, 2024

SELL
$46.37 - $73.65 $80,730 - $128,224
-1,741 Reduced 1.15%
149,552 $10.7 Million
Q3 2023

Nov 07, 2023

BUY
$52.09 - $64.1 $7.88 Million - $9.7 Million
151,293 New
151,293 $7.88 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $6.47B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.